Rocket Lab earnings analysis: questions answered and next catalysts
Rocket Lab Corp (RKLB) reported Q3 FY2026 revenue of $268.0M, beating estimates, but missed earnings with EPS of -$0.12. Backlog grew to $3.6B, and Neutron launches were priced higher. The stock initially dropped but reversed, trading at $60.69. Unresolved issues include Neutron delays and cost overruns. Next catalysts include Iridium approval, Neutron progress, and Q4 results.
How this was made
The 30-second read
Why it matters
The earnings miss and cost overruns create short‑term downside risk, while the sizable backlog and upcoming Neutron contracts provide upside catalysts.
Market read
First‑report earnings data with fresh guidance and backlog details, directly affecting RKLB's valuation.
What to watch
Potential regulatory approval for the Iridium deal could convert Rocket Lab into an operator, adding a new revenue stream.
Background
Rocket Lab's Q3 earnings were released on Nov 9, 2026, showing a 73% YoY revenue increase but a GAAP EPS miss and higher operating costs.
Ticker impact
Rocket Lab reported Q3 FY2026 earnings with revenue beat but EPS miss, providing fresh guidance and backlog details.
likely pressure as the market prices in the earnings miss and cost overruns
The surprise EPS miss and higher-than-expected expenses are fresh data that can move the stock in the near term.
Market effects
Highlights execution risk in the small‑sat launch sector and may affect peers like Astra and Virgin Orbit.
U.S. space launch market sentiment could soften pending upcoming contract announcements.
Shows demand for launch services remains strong, but cost and schedule issues could temper investor enthusiasm globally.
Counterpoint
Backlog growth and record revenue suggest a longer‑term bullish case if Neutron delays are resolved.
Key entities
- companyRocket Lab Corp
U.S. listed space launch provider (ticker RKLB).





